Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia Clinical Trial
Official title:
A Randomized Open Label Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Klebsiella pneumonia, inhabitant of the digestive tract, is a frequent nosocomial pathogen.
It is currently the fourth most common cause of pneumonia and fifth most common cause of
bacteremia in intensive care patients (1-3).
The aim of the present randomized controlled trial is to assess the efficacy of
non-absorbable oral antibiotics in the eradication of the KPC carrier state.
n/a